Accessibility Menu
Convatec Group Plc logo

Convatec Group Plc(OTC) CNVVY

Market Cap$6.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+18%
5 Year+8%
1 Year-1%
1 Month+1%
$12.47
-1.89%
-0.24Today
Convatec Group Plc last closing stock price
MetricPriceDate
Last closeUSD 12.472026-09-03
Convatec Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.42%USD 12.652026-08-27
1 month+1.02%USD 12.342026-08-04
3 month+14.16%USD 10.922026-06-05
Year to date-2.32%USD 12.772025-12-31
1 year-0.57%USD 12.542025-09-03
3 year+13.85%USD 10.952023-09-01
5 year+8.1%USD 11.542021-09-02
Since inception+17.79%USD 10.792017-01-26

Convatec Group Plc Financials at a Glance

Market Cap

$6.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.84B

Net Income (TTM)

$339.50M

EPS (TTM)

$0.25

P/E Ratio

51.46

Dividend

$0.30

Beta (Volatility)

0.29 (Low)

Price

$12.47

Volume

16,232

Open

$12.65

Previous Close

$12.47

Daily Range

$12.33 - $12.67

52-Week Range

$10.45 - $14.09

Estimated Earnings Date

Feb 23, 2027

CNVVY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Convatec Group Plc

ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company focuses on advanced wound care, ostomy care, and continence solutions, addressing the needs of patients with various medical conditions.

Products and Services
  • Advanced wound care solutions for acute and chronic wounds
  • Comprehensive ostomy care devices and support services
  • Continence and critical care products for hospital settings
Growth Outlook
  • Revenue of $1.23 billion in Q2 2026, showing strong demand
  • Operating income margin of 14.5% indicates efficient cost management
  • Continued investment in R&D to drive product innovation
Financial Highlights
  • Net income of $53.99 million in Q2 2026, reflecting solid profitability
  • Gross profit margin of 54.3% demonstrates strong pricing power
  • Dividend yield of 1.32% offers attractive returns to shareholders
ConvaTec Group Plc is well-positioned in the healthcare sector, focusing on innovative solutions that cater to the needs of patients and healthcare providers. The company's diverse product portfolio and commitment to research and development support its growth trajectory. Recent financial performance highlights a robust revenue stream and profitability, making it an intriguing option for potential investors interested in the medical technology industry.
AI Generated • Aug 29, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10,910

CEO

Jonathan Peter Mason, MBA

Website

www.convatec.com

Headquarters

London, GL W2 6LG, GB

CNVVY Financials

Key Financial Metrics (TTM)

Gross Margin

55.07%

Operating Margin

16.16%

Net Income Margin

4.99%

Return on Equity

8.40%

Return on Capital

13.44%

Return on Assets

3.26%

Earnings Yield

1.94%

Dividend Yield

2.36%

Payout Ratio

1.12%

Stock Overview

Market Cap

$6.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

485.49M

Volume

16.23K

Avg. Volume

26.13K

Financials (TTM)

Gross Profit

$2.67B

Operating Income

$765.76M

EBITDA

$1.21B

Operating Cash Flow

$857.80M

Capital Expenditure

-$319.85M

Free Cash Flow

$537.95M

Cash & ST Invst.

$99.00M

Total Debt

$1.74B

Convatec Group Plc Performance Analysis

Convatec Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,071,220,9781.6%
20232023-12-31USD 2,150,704,0963.8%
20242024-12-31USD 2,290,163,2706.5%
20252025-12-31USD 2,444,699,6286.7%
Convatec Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-315.7%
Q22025-06-300.3%
Q42025-12-316.3%
Q22026-06-30-1.8%
Convatec Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.12-46.9%
20232023-12-31USD 0.25106.9%
20242024-12-31USD 0.3745.4%
20252025-12-31USD 0.34-6.9%
Convatec Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3141.1%
Q22025-06-30-5.4%
Q42025-12-31-31.4%
Q22026-06-30-21.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.23B

+10.6%

Gross Profit

$668.87M

+7.2%

Gross Margin

54.30%

N/A

Market Cap

$6.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$565.59K

N/A

Employees

10,910

N/A

Net Income

$53.99M

-31.3%

EBITDA

$290.95M

+16.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$99.00M

+2.2%

Total Debt

$1.74B

+23.3%

Accounts Receivable

$456.00M

+32.7%

Inventory

$435.00M

+14.9%

Long Term Debt

$1.72B

+23.4%

Short Term Debt

$25.00M

+19.6%

Return on Assets

3.26%

N/A

Return on Invested Capital

12.22%

N/A

Free Cash Flow

-$55.99M

-344.5%

Operating Cash Flow

$71.99M

-2.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SKHCFSonic Healthcare Limited
$13.65+0.00%
SKHHYSonic Healthcare Limited
$13.79-0.33%
GNGBYGetinge AB (publ)
$25.20+0.00%
SHPMYShanghai Pharmaceuticals Holding Co., Ltd
$7.24+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About CNVVY

What is the current price of Convatec Group Plc?

Convatec Group Plc is trading at $12.47 per share.

What is the 52-week range for Convatec Group Plc?

Over the past 52 weeks, Convatec Group Plc has traded between $10.45 and $14.09.

How much debt does Convatec Group Plc have?

As of the most recent reporting period, Convatec Group Plc reported total debt of $1.52B.

How much cash does Convatec Group Plc have on hand?

Convatec Group Plc reported $75.00M in cash and cash equivalents in its most recent financial results.

What is Convatec Group Plc’s dividend yield?

Convatec Group Plc currently has a dividend yield of 2.36%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services